Ad blocking detected

Thank you for visiting CanadianInsider.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). Private browsing Firefox users should be able to disable tracking protection while visiting our website. Visit Mozilla support for more information. If you do not believe you have any ad-blocking software on your browser, you may want to try another browser, computer or internet service provider. Alternatively, you may consider the following if you want an ad-free experience.

Canadian Insider Ultra Club
$500/ year*
Daily Morning INK newsletter
+3 months archive
Canadian Market INK weekly newsletter
+3 months archive
30 publication downloads per month from the PDF store
Top 20 Gold, Top 30 Energy, Top 40 Stock downloads from the PDF store
All benefits of basic registration
No 3rd party display ads
JOIN THE CLUB

* Price is subject to applicable taxes.

Paid subscriptions and memberships are auto-renewing unless cancelled (easily done via the Account Settings Membership Status page after logging in). Once cancelled, a subscription or membership will terminate at the end of the current term.

Isracann Biosciences Inc. (C:IPOT)

Business Focus: Alternative Medicine

Get the company report for the most recent outlook updated daily

Insider Chart - Past 6 Months

Insider Filings

Latest 10 SEDI filings for IPOT within the last 6 months
Loading...
See all filings within the past 6 months

Company News

Apr 06, 2023 11:34 ET
CSE Bulletin: Suspensions (IPOT, TCAN)
Toronto, Ontario--(Newsfile Corp. - Le 6 avril/April 2023) - Effective immediately, the following companies are suspended pursuant to CSE Policy 3. The suspensions are considered Regulatory Halts as defined in National Instrument 23-101 Trading Rules. Cease Trade Orders have been issued by one or more securities commissions.
Read full article
Apr 06, 2023 09:39 ET
IIROC Trading Halt - IPOT
VANCOUVER, BC, April 6, 2023 /CNW/ - The following issues have been halted by IIROC:
Read full article
See more news stories

Valuation Ratios

Industry
Sector
Beta
0.04
--
--
Price to Sales - TTM
--
2.41
3.45
Price to Book - most recent quarter
19.07
1.06
2.04
Price to Cash Flow per share - TTM
--
--
10.35
Price to Free Cash Flow per share - TTM
--
7.15
12.34
See all valuations

Short Report

DateNumber of Shares ShortedNet Change
Mar 15, 20242400
Feb 29, 20242400
Feb 15, 20242400
See Short Report

Business Summary

Sector:  Healthcare Industry:  Pharmaceuticals

Isracann Biosciences Inc. is a Canada-based cannabis company. The principal business focus of the Company is medical cannabis cultivation and distribution to provide products to the Israeli medical cannabis market, and to develop and validate Natural Health Products (NHP), through the Company's operating subsidiaries. The Company's segments include Head Office, Medical Cannabis and Natural Health Product. The Company aims to commercialize natural health medicines in Canada and to leverage agreements within Israel for import/export opportunities and medicinal marijuana cultivation. The Company's subsidiaries include Isracann Holdings Inc., Praesidio Health Inc., Isracann Biosciences Capital Ltd., Isracann Operations Ltd., Isracann Development Ltd., Isracann Agritech Ltd., Isracann Administrative Services Ltd. and others.

See business summary

 

Twitter

Search (past week) for $IPOT.CA

  • No tweets found